SynAct Pharma AB Net Asset Quality Index
SynAct Pharma AB net asset quality index. SynAct Pharma AB (SYNACT) has a Net Asset Quality Index of 81.4% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Skr237.88 Million minus total liabilities of Skr44.13 Million yields net assets of Skr193.75 Million. A higher index indicates a stronger, lower-leverage balance sheet. See SYNACT net asset value for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of SynAct Pharma AB (2014–2025)
Net asset quality index of SynAct Pharma AB from 2014 to 2025. This chart shows how SynAct Pharma AB's Net Asset Quality Index has evolved across 12 annual periods from 2014 to 2025. As of March 2026, the index stands at 81.4%, representing net assets of Skr193.75 Million against total assets of Skr237.88 Million SEK. Check asset allocation strategy of SynAct Pharma AB to assess the company's strategic physical and investment asset allocation.
SynAct Pharma AB Net Asset Quality Index by Year (2014–2025)
SynAct Pharma AB net asset quality index by year from 2014 to 2025. The table below presents the year-by-year Net Asset Quality Index for SynAct Pharma AB from 2014 to 2025, covering 12 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see SynAct Pharma AB (SYNACT) market capitalisation.
| Year | Quality Index | Net Assets (SEK) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 77.2% | Skr170.29 Million | Skr220.52 Million | Skr50.23 Million | ▼ -1.9 pp |
| 2024 | 79.2% | Skr214.17 Million | Skr270.52 Million | Skr56.35 Million | ▲ +1.9 pp |
| 2023 | 77.3% | Skr176.19 Million | Skr228.02 Million | Skr51.83 Million | ▼ -11.5 pp |
| 2022 | 88.7% | Skr126.52 Million | Skr142.60 Million | Skr16.08 Million | ▲ +34.3 pp |
| 2021 | 54.4% | Skr20.87 Million | Skr38.37 Million | Skr17.50 Million | ▼ -19.1 pp |
| 2020 | 73.5% | Skr15.87 Million | Skr21.59 Million | Skr5.72 Million | ▲ +16.8 pp |
| 2019 | 56.7% | Skr13.50 Million | Skr23.81 Million | Skr10.31 Million | ▼ -16.8 pp |
| 2018 | 73.5% | Skr10.31 Million | Skr14.03 Million | Skr3.72 Million | ▼ -11.3 pp |
| 2017 | 84.8% | Skr12.91 Million | Skr15.23 Million | Skr2.31 Million | ▼ -3.8 pp |
| 2016 | 88.6% | Skr27.08 Million | Skr30.57 Million | Skr3.49 Million | ▲ +3.7 pp |
| 2015 | 84.9% | Skr320.00K | Skr377.00K | Skr57.00K | ▼ -3.9 pp |
| 2014 | 88.8% | Skr642.00K | Skr723.00K | Skr81.00K | — |